PTPRC and neoplasm: In addition to facilitating the entry of effector T cells into tumor tissues, PI also promotes the entry of other immune cells, such as CD45+ leukocytes (observed in the current study), including NK cells and DCs (observed in our previous study [15], into tumor tissues.